eCARTv5 Clinical Deterioration Suite (eCART) vs UpDoc

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

eCARTv5 Clinical Deterioration Suite (eCART)

by AgileMD

UpDoc

by UpDoc

AI Verdict

eCARTv5 focuses on predicting acute clinical deterioration (death or ICU transfer) in hospitalized patients, providing early warnings and guiding care pathways. UpDoc, on the other hand, is designed for continuous, physician-level care and evidence-based interventions for chronic disease management between patient visits. While both are FDA-cleared, AI-powered, and integrate with EHRs, their distinct target patient populations and care delivery models make them adjacent rather than direct competitors.

Choose eCARTv5 Clinical Deterioration Suite (eCART) if…

Choose eCARTv5 Clinical Deterioration Suite if your primary goal is to proactively identify and manage acute clinical deterioration in hospitalized adult patients. This tool excels at continuous, real-time risk assessment for events like death or ICU transfer, providing early warnings and guiding care with embedded clinical pathways to improve inpatient outcomes and reduce clinician workload.

View eCARTv5 Clinical Deterioration Suite (eCART) →

Choose UpDoc if…

Choose UpDoc if your focus is on delivering continuous, evidence-based clinical interventions and physician-level care for chronic disease management between patient visits. This AI platform is ideal for extending care beyond the clinic, engaging patients, gathering structured health information, and coordinating with care teams to improve long-term chronic disease outcomes.

View UpDoc →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	eCARTv5 Clinical Deterioration Suite (eCART)	UpDoc
Pricing	Contact vendor for tailored quote.	Unknown
Deployment	Cloud-based SaaS, integrated directly into Electronic Health Record (EHR) systems.	Cloud-based application, integrated with EHR systems.
FDA Status	1 AI-estimated	1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

UpDoc

UpDoc offers a patient mobile app and supports multiple languages, suggesting a broader focus on user accessibility and engagement for both clinicians and patients. eCART focuses on EHR integration and clinical pathways, which is crucial for clinician usability, but lacks explicit mention of patient-facing tools or multi-language support.

Clinical Value

Tie

Both tools are FDA-cleared and offer significant clinical value in their respective domains. eCART provides continuous risk assessment and early warning for clinical deterioration in hospitalized patients, while UpDoc delivers physician-level care and continuous interventions for chronic disease management. Their value propositions are distinct but equally impactful within their target areas.

Pricing & Value

UpDoc

UpDoc provides some transparency regarding its pricing model, mentioning unlimited consultations for a monthly fee in its Australian platform, which implies a subscription-based model. eCART's pricing is 'contact vendor for tailored quote,' offering no public information, making it harder for prospective customers to assess initial value without direct engagement.

Enterprise Readiness

Tie

Both tools demonstrate strong enterprise readiness. eCART emphasizes deep EHR integration and reporting/benchmarking capabilities, crucial for large health systems. UpDoc also highlights EHR and workflow integration, SOC 2 compliance, and targets 'Enterprise health systems.' Both are cloud-based SaaS solutions with HIPAA compliance and BAA, indicating readiness for large-scale deployment.

Innovation

UpDoc

UpDoc's claim of 'FDA-Cleared Agentic AI' that delivers 'physician-level care' and 'continuous, evidence-based clinical interventions' between visits represents a highly innovative approach to chronic disease management. While eCART's continuous deterioration prediction is also innovative, UpDoc's agentic AI for direct patient intervention pushes the boundaries of AI in clinical care.

Support & Docs

Tie

Neither product's provided information or readily available public web content explicitly details their support structures or documentation availability. While both are enterprise-grade solutions, implying robust support, there isn't enough specific information to differentiate them on this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	eCARTv5 Clinical Deterioration Suite (eCART)	UpDoc
Name	eCARTv5 Clinical Deterioration Suite (u201ceCARTu201d)	UpDoc
Company	AgileMD	UpDoc
Description	FDA-cleared, AI-powered Software as a Medical Device (SaMD) that integrates with EHRs to continuously assess and predict the risk of clinical deterioration (death or ICU transfer) in hospitalized adult patients, guiding care with embedded clinical pathways.	FDA-cleared AI platform that delivers physician-level care and continuous, evidence-based clinical interventions for chronic disease management between patient visits.
Key Features	AI-powered clinical deterioration prediction, Continuous patient risk assessment (death or ICU transfer), EHR integration with real-time data (up to 97 variables), Embedded clinical pathways for care guidance, Early warning system (alerts hours before critical illness), Risk stratification (eCART score and risk designation), Minimizes false alarms and clinician workload, Reporting and benchmarking capabilities	FDA-Cleared Agentic AI, EHR and Workflow Integrated, Connect with patients between visits, Gather structured health information, Coordinate with care teams, Deliver physician-level interventions, Continuous, evidence-based clinical intervention, Physician governed accountability
Specialties	Critical Care, Emergency Medicine, Hospital Medicine	Endocrinology, Family Medicine, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring eCARTv5 Clinical Deterioration Suite (eCART) and UpDoc.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do eCART and UpDoc integrate with existing EHR systems, and what is the depth of data exchange for each?

eCART integrates with EHRs to pull up to 97 variables in real-time for continuous patient risk assessment and embeds clinical pathways directly. UpDoc also integrates with EHRs to facilitate workflow and gather structured health information, enabling continuous, evidence-based clinical interventions and care coordination between visits.

What is the primary clinical application and target patient population for each tool, and how does this affect workflow fit for a physician?

eCART is designed for hospitalized adult patients, predicting clinical deterioration (death or ICU transfer) and guiding care with early warnings and pathways, fitting into acute care workflows. UpDoc focuses on chronic disease management between visits, delivering physician-level interventions and engaging patients via a mobile app, which would integrate into outpatient and longitudinal care workflows.

Given their different clinical focuses, how do eCART and UpDoc ensure accuracy and sensitivity in their respective predictions and interventions?

eCART uses AI to continuously assess and predict clinical deterioration, aiming to minimize false alarms and clinician workload through its risk stratification. UpDoc utilizes FDA-cleared Agentic AI to deliver physician-level care and continuous, evidence-based clinical interventions for chronic disease management, implying a focus on accurate and appropriate guidance for long-term conditions.

What is the expected learning curve for physicians and care teams to effectively utilize eCART versus UpDoc in their daily practice?

eCART's integration with embedded clinical pathways and real-time alerts suggests a system designed to guide actions within existing acute care workflows, potentially simplifying adoption. UpDoc's focus on between-visit care and patient engagement via a mobile app may require physicians to adapt to new methods of interaction and intervention delivery for chronic disease management.

How do eCART and UpDoc support audit trails and accountability for the AI-driven decisions and interventions they provide?

eCART offers reporting and benchmarking capabilities, which can contribute to auditing the impact and effectiveness of its deterioration predictions and pathway adherence. UpDoc emphasizes 'Physician governed accountability' for its FDA-cleared Agentic AI, suggesting features are in place to track and attribute AI-driven interventions.

For a multi-site health system, what considerations should be made regarding the rollout and scalability of eCART compared to UpDoc?

eCART's focus on acute care within hospitals suggests a rollout strategy centered on hospital-based implementations, leveraging its EHR integration for continuous monitoring. UpDoc, targeting enterprise health systems for chronic disease management and patient engagement, would likely involve a broader rollout across outpatient clinics and patient populations, potentially utilizing its multi-language support and patient mobile app for wider adoption.